Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)

Trial Profile

Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Mar 2018

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Acenocoumarol
  • Indications Embolism; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SEDMAN
  • Most Recent Events

    • 19 Mar 2018 Planned primary completion date changed from 1 Apr 2017 to 1 Jun 2019.
    • 19 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 28 Jun 2016 Planned initiation date changed from 1 Apr 2016 to 1 Jun 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top